The conclusions from ICER’s cost-effectiveness evaluations can impact patients’ access to needed treatments. It is imperative, consequently, that ICER’s value assessment framework properly incorporates all potential benefits that a treatment can offer patients, including those benefits that are difficult to quantify or are unquantifiable.
